Federal contractor profile
Leidos Biomedical Research: Federal Contracts, Agencies & Awards
Data through 2026-09-08 · FY2026 to date
- Obligations, FY2026 to date
- $303M
- Contract awards
- 105
- Average award size
- $2.9M
- vs. prior full fiscal year
- 45.9% decline
| Item | Obligations |
|---|---|
| FY21 | $935M |
| FY22 | $982M |
| FY23 | $1.2B |
| FY24 | $869M |
| FY25 | $560M |
| FY26 | $303M |
Obligations fell 45.9% year over year, from $560M in FY2025 to $303M in FY2026 to date.
Leidos Biomedical Research obligated $303M in federal contracts in FY2026 to date. Leidos Biomedical Research won 105 awards in the period, with an average award size of $2.9M, and obligations are down 45.9% year over year. Leidos Biomedical Research recorded obligations of $935M in FY21, $982M in FY22, $1.2B in FY23, $869M in FY24, $560M in FY25, and $303M in FY26. Leidos Biomedical Research shows Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) as a top NAICS market at $305M. The current-year totals are partial (fiscal year to date) and the page notes that figures are contract obligations except where award-value is specified in the largest-awards and expiring-contracts tables. These figures place FY2026 to date well below recent peak years, and they reflect the fiscal-year-to-date snapshot provided on the vendor page.
What changed in FY2026 to date?
Leidos Biomedical Research obligated $303M in FY2026 to date, down 45.9% year over year. Leidos Biomedical Research won 105 awards in the period, with an average award size of $2.9M. Leidos Biomedical Research previously recorded $560M in FY25 and $1.2B in FY23, showing a decline into FY26.
| Item | Obligations |
|---|---|
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $305M |
| Facilities Support Services | -$2.1M |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) is Leidos Biomedical Research's largest federal market, with $305M in obligations.
Where do Leidos Biomedical Research obligations come from?
Leidos Biomedical Research records $305M in Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). Leidos Biomedical Research also reports obligations in Facilities Support Services, without a listed dollar total on this page. The FY21 through FY26 series shows multi-year obligation totals that contextualize current-year activity.
| Rank | Award | Award Amount | Awarding Agency | Ends |
|---|---|---|---|---|
| 1 | HHSN261200800001E | $4.8B | Department of Health and Human Services | 2024-09-06 |
| 2 | 75N91020F00003 | $1.8B | Department of Health and Human Services | 2024-09-27 |
| 3 | 75N91025F00016 | $485M | Department of Health and Human Services | 2027-08-30 |
| 4 | 75N91019F00129 | $432M | Department of Health and Human Services | 2026-05-21 |
| 5 | 75N91020F00039 | $234M | Department of Health and Human Services | 2029-09-29 |
| 6 | 75N91019F00139 | $181M | Department of Health and Human Services | 2029-10-31 |
| 7 | 75N91023F00008 | $173M | Department of Health and Human Services | 2029-05-31 |
| 8 | 75N91021F00004 | $142M | Department of Health and Human Services | 2031-01-28 |
| 9 | 75N91019F00133 | $126M | Department of Health and Human Services | 2024-08-30 |
| 10 | 75N91020F00006 | $122M | Department of Health and Human Services | 2024-08-30 |
| 11 | 75N91021F00013 | $92.1M | Department of Health and Human Services | 2028-02-28 |
| 12 | 75N91025F00014 | $87.8M | Department of Health and Human Services | 2027-08-30 |
| 13 | 75N91021F00001 | $79.9M | Department of Health and Human Services | 2026-10-31 |
| 14 | 75N91025F00012 | $77.6M | Department of Health and Human Services | 2026-08-30 |
| 15 | 75N91019F00130 | $63.1M | Department of Health and Human Services | 2020-08-30 |
| 16 | 75N91020F00021 | $45.9M | Department of Health and Human Services | 2030-08-31 |
| 17 | 75N91020F00030 | $37.7M | Department of Health and Human Services | 2027-08-30 |
| 18 | 75N91019F00134 | $32.7M | Department of Health and Human Services | 2026-09-30 |
| 19 | 75N91025F00005 | $28.5M | Department of Health and Human Services | 2026-08-30 |
| 20 | HHSN26100019 | $27.5M | Department of Health and Human Services | 2021-09-18 |
| 21 | 75N91024F00027 | $27M | Department of Health and Human Services | 2025-08-30 |
| 22 | 75N91022F00013 | $25.1M | Department of Health and Human Services | 2030-06-17 |
| 23 | 75N91019F00138 | $24.1M | Department of Health and Human Services | 2029-09-18 |
| 24 | 75N91022F00019 | $22.4M | Department of Health and Human Services | 2027-09-08 |
| 25 | 75N91021F00017 | $21.7M | Department of Health and Human Services | 2029-08-21 |
| Award | Awarding Agency | Award Value | Ends |
|---|---|---|---|
| 75N91025F00016 | Department of Health and Human Services | $485M | 2027-08-30 |
| 75N91025F00014 | Department of Health and Human Services | $87.8M | 2027-08-30 |
| 75N91021F00001 | Department of Health and Human Services | $79.9M | 2026-10-31 |
| 75N91018F00071 | Department of Health and Human Services | $67M | 2027-08-31 |
| 75N91020F00026 | Department of Health and Human Services | $56.5M | 2027-05-25 |
| 75N91020F00030 | Department of Health and Human Services | $37.7M | 2027-08-30 |
| 75N91019F00134 | Department of Health and Human Services | $32.7M | 2026-09-30 |
| 75N91022F00019 | Department of Health and Human Services | $22.4M | 2027-09-08 |
| 75N91021F00015 | Department of Health and Human Services | $20.4M | 2027-04-30 |
| HHSN26100039 | Department of Health and Human Services | $19.8M | 2026-09-30 |
| Detail | Registration |
|---|---|
| Unique Entity ID (UEI) | HV8BH9BPG8Y9 |
| Headquarters | Frederick, MD |
| Parent company | LEIDOS HOLDINGS, INC. |
| Business types | Category business; Corporate entity not tax exempt; Other than small business; Special designations; Us owned business |
This is the free layer.
GovHub customers get the live version, filters, exports, and AI proposal drafting on top of this data.
No credit card required · 14-day free trial
Frequently asked questions
How much does Leidos Biomedical Research make from federal contracts?
Leidos Biomedical Research made $303M from federal contracts in FY2026 to date. Leidos Biomedical Research won 105 awards in the period, with an average award size of $2.9M, and obligations are down 45.9% year over year; prior-year totals include $560M in FY25 and $1.2B in FY23.
Which agencies buy from Leidos Biomedical Research?
No agency breakdown is listed on this page. The page does not provide a list of which agencies purchased from Leidos Biomedical Research for FY2026 to date.
What does Leidos Biomedical Research sell to the government?
Leidos Biomedical Research sells research and development services recorded as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at $305M. Leidos Biomedical Research also lists Facilities Support Services as a market on the page without a dollar total shown here.
Which Leidos Biomedical Research contracts are expiring soon?
No expiring contracts are listed on this page. The page does not provide a table of contracts that are expiring soon for Leidos Biomedical Research.
Found your market? GovHub writes the proposal.
Turn this market intelligence into a submitted, compliant federal proposal, faster.
No credit card required · 14-day free trial